
1. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors
Citations:1298
Authors: A Bamias, E Kastritis, C Bamia, LA Moulopoulos, I Melakopoulos, ...
Publication: J Clin Oncol 23 (34), 8580-7

2. Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small …
Citations:790
Authors: H Linardou, IJ Dahabreh, D Kanaloupiti, F Siannis, D Bafaloukos, ...
Publication: The lancet oncology 9 (10), 962-972

3. Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study …
Citations:192
Authors: A Bamias, G Aravantinos, C Deliveliotis, D Bafaloukos, C Kalofonos, ...
Publication: Journal of Clinical Oncology 22 (2), 220-228

5. Front-line treatment of advanced non–small-cell lung cancer with docetaxel and gemcitabine: A multicenter phase II trial
Citations:149
Authors: V Georgoulias, C Kouroussis, N Androulakis, S Kakolyris, MA Dimopoulos, ...
Publication: Journal of clinical oncology 17 (3), 914-914

8. Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II study
Citations:107
Authors: N Androulakis, C Kourousis, MA Dimopoulos, G Samelis, S Kakolyris, ...
Publication: Journal of clinical oncology 17 (6), 1779-1779

9. Outcomes after adjuvant chemotherapy in the treatment of high‐risk urothelial carcinoma of the upper urinary tract (UUT‐UC) Results from a large multicenter collaborative study
Citations:101
Authors: M Vassilakopoulou, T de la Motte Rouge, P Colin, A Ouzzane, D Khayat, ...
Publication: Cancer 117 (24), 5500-5508

11. Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications
Citations:98
Authors: A Soultati, G Mountzios, C Avgerinou, G Papaxoinis, D Pectasides, ...
Publication: Cancer treatment reviews 38 (5), 473-483

13. Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): A …
Citations:86
Authors: P Kosmidis, N Mylonakis, D Skarlos, E Samantas, M Dimopoulos, ...
Publication: Annals of oncology 11 (7), 799-805

15. Granulosa cell tumor of the ovary: tumor review
Citations:80
Authors: GV Koukourakis, VE Kouloulias, MJ Koukourakis, GA Zacharias, ...
Publication: Integrative cancer therapies 7 (3), 204-215

18. A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer
Citations:73
Authors: G Fountzilas, U Dafni, MA Dimopoulos, A Koutras, D Skarlos, ...
Publication: Breast cancer research and treatment 115 (1), 87

20. Outpatient treatment of low‐risk neutropenic fever in cancer patients using oral moxifloxacin
Citations:67
Authors: G Chamilos, A Bamias, E Efstathiou, PM Zorzou, E Kastritis, E Kostis, ...
Publication: Cancer 103 (12), 2629-2635

21. The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy
Citations:66
Authors: A Bamias, E Efstathiou, LA Moulopoulos, D Gika, G Hamilos, MP Zorzou, ...
Publication: Annals of oncology 16 (2), 307-313

22. Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative …
Citations:65
Authors: D Tousoulis, I Andreou, M Tsiatas, A Miliou, C Tentolouris, G Siasos, ...
Publication: Atherosclerosis 214 (1), 151-157

23. Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum‐paclitaxel chemotherapy
Citations:64
Authors: A Bamias, T Psaltopoulou, M Sotiropoulou, D Haidopoulos, E Lianos, ...
Publication: Cancer: Interdisciplinary International Journal of the American Cancer …

25. Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study
Citations:61
Authors: I Andreou, D Tousoulis, A Miliou, C Tentolouris, K Zisimos, P Gounari, ...
Publication: Atherosclerosis 210 (1), 194-198

29. Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamide
Citations:54
Authors: MA Dimopoulos, G Hamilos, E Efstathiou, I Siapkaras, C Matsouka, ...
Publication: Leukemia & lymphoma 44 (6), 993-996

32. Endometrial cancer: what is new in adjuvant and molecularly targeted therapy?
Citations:50
Authors: F Zagouri, G Bozas, E Kafantari, M Tsiatas, N Nikitas, MA Dimopoulos, ...
Publication: Obstetrics and gynecology international 2010

39. High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer
Citations:45
Authors: F Zagouri, Z Bago-Horvath, F Rössler, A Brandstetter, R Bartsch, ...
Publication: British journal of cancer 108 (5), 1100

40. Taxanes for breast cancer during pregnancy: a systematic review
Citations:45
Authors: F Zagouri, TN Sergentanis, D Chrysikos, C Dimitrakakis, A Tsigginou, ...
Publication: Clinical breast cancer 13 (1), 16-23

41. Developments in the systemic treatment of metastatic cervical cancer
Citations:43
Authors: G Mountzios, A Soultati, D Pectasides, E Pectasides, MA Dimopoulos, ...
Publication: Cancer treatment reviews 39 (5), 430-443

43. Phase II study of docetaxel–vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer
Citations:42
Authors: G Aravantinos, D Bafaloukos, G Fountzilas, C Christodoulou, ...
Publication: Annals of oncology 14 (7), 1094-1099

44. Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative …
Citations:41
Authors: G Fountzilas, U Dafni, H Gogas, H Linardou, HP Kalofonos, E Briasoulis, ...
Publication: Annals of oncology 19 (5), 853-860

45. A prospective study on lung toxicity in patients treated with gemcitabine and carboplatin: clinical, radiological and functional assessment
Citations:41
Authors: I Dimopoulou, E Efstathiou, A Samakovli, U Dafni, LA Moulopoulos, ...
Publication: Annals of Oncology 15 (8), 1250-1255

50. Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic …
Citations:39
Authors: G Fountzilas, D Pectasides, A Kalogera-Fountzila, D Skarlos, ...
Publication: Breast cancer research and treatment 92 (1), 1-9

51. The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy
Citations:38
Authors: E Kastritis, A Bamias, E Efstathiou, D Gika, G Bozas, P Zorzou, K Sarris, ...
Publication: Gynecologic oncology 99 (2), 376-382

52. Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem‐cell transplantation: Results of a single institution, randomized phase …
Citations:37
Authors: E Eleutherakis‐Papaiakovou, E Kostis, M Migkou, D Christoulas, ...
Publication: American journal of hematology 85 (11), 863-867

53. Paraneoplastic humorally mediated hypercalcemia induced by parathyroid hormone-related protein in gynecologic malignancies: a systematic review
Citations:37
Authors: P Savvari, P Peitsidis, M Alevizaki, MA Dimopoulos, A Antsaklis, ...
Publication: Oncology Research and Treatment 32 (8-9), 517-523

58. Clinicopathological features of ovarian carcinosarcomas: a single institution experience
Citations:34
Authors: MP Zorzou, S Markaki, A Rodolakis, E Kastritis, G Bozas, MA Dimopoulos, ...
Publication: Gynecologic oncology 96 (1), 136-142

62. Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinoma
Citations:33
Authors: G Bozas, A Bamias, V Koutsoukou, E Efstathiou, D Gika, ...
Publication: Gynecologic oncology 104 (3), 580-585

66. The key role of bisphosphonates in the supportive care of cancer patients
Citations:31
Authors: M Tolia, A Zygogianni, JR Kouvaris, C Meristoudis, N Margari, ...
Publication: Anticancer research 34 (1), 23-37

67. Developments in the systemic treatment of endometrial cancer
Citations:31
Authors: G Mountzios, D Pectasides, E Bournakis, E Pectasides, G Bozas, ...
Publication: Critical reviews in oncology/hematology 79 (3), 278-292

68. The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy
Citations:31
Authors: E Kastritis, A Bamias, G Bozas, V Koutsoukou, Z Voulgaris, G Vlahos, ...
Publication: Gynecologic oncology 104 (2), 372-376

69. The prognostic significance of the immunohistochemical expression of p53, bcl-2, c-erb B-2 and cathepsin-D in ovarian cancer patients receiving platinum with cyclophosphamide …
Citations:31
Authors: A Protopapas, E Diakomanolis, A Bamias, S Milingos, S Markaki, ...
Publication: European journal of gynaecological oncology 25 (2), 225-229

70. HSP90, HSPA8, HIF-1 alpha and HSP70-2 polymorphisms in breast cancer: a case–control study
Citations:29
Authors: F Zagouri, TN Sergentanis, M Gazouli, A Tsigginou, C Dimitrakakis, ...
Publication: Molecular biology reports 39 (12), 10873-10879

71. Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker …
Citations:29
Authors: G Fountzilas, HP Kourea, M Bobos, D Televantou, V Kotoula, ...
Publication: Anticancer research 31 (9), 3007-3018

72. Docetaxel (Taxotere) and gemcitabine in the treatment of non-small cell lung cancer: preliminary results.
Citations:29
Authors: V Georgoulias, C Kourousis, N Androulakis, S Kakolyris, MA Dimopoulos, ...
Publication: Seminars in oncology 24 (4 Suppl 14), S14-22-S14-25

74. Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with …
Citations:28
Authors: G Fountzilas, U Dafni, M Bobos, V Kotoula, A Batistatou, I Xanthakis, ...
Publication: BMC cancer 13 (1), 163

75. Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases
Citations:28
Authors: AV Stavropoulou, F Fostira, M Pertesi, M Tsitlaidou, GE Voutsinas, ...
Publication: PloS one 8 (3), e58182

76. Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases
Citations:28
Authors: AV Stavropoulou, F Fostira, M Pertesi, M Tsitlaidou, GE Voutsinas, ...
Publication: PloS one 8 (3), e58182

78. Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a …
Citations:28
Authors: G Aravantinos, G Fountzilas, P Kosmidis, MA Dimopoulos, ...
Publication: Annals of oncology 16 (7), 1116-1122

80. Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment
Citations:27
Authors: E Efstathiou, G Bozas, A Kostakopoulos, E Kastritis, C Deliveliotis, ...
Publication: Urology 65 (1), 126-130

82. VTD consolidation, without bisphosphonates, reduces bone resorption and is associated with a very low incidence of skeletal-related events in myeloma patients post ASCT
Citations:26
Authors: E Terpos, D Christoulas, E Kastritis, M Roussou, M Migkou, ...
Publication: Leukemia 28 (4), 928

88. Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancer
Citations:24
Authors: I Mountzios, E Bournakis, E Efstathiou, A Varkaris, S Wen, M Chrisofos, ...
Publication: Urology 77 (3), 682-687

89. Young age is associated with favorable characteristics but is not an independent prognostic factor in patients with epithelial ovarian cancer: a single institution experience
Citations:24
Authors: G Bozas, MA Dimopoulos, E Kastritis, E Efstathiou, V Koutsoukou, ...
Publication: Oncology 70 (4), 265-272

91. Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context …
Citations:23
Authors: P Skarlos, C Christodoulou, KT Kalogeras, AG Eleftheraki, M Bobos, ...
Publication: Cancer chemotherapy and pharmacology 69 (2), 533-546

92. Low frequency of somatic mutations in uterine sarcomas: a molecular analysis and review of the literature
Citations:23
Authors: S Murray, H Linardou, G Mountzios, M Manoloukos, S Markaki, ...
Publication: Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 686 (1 …

93. Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative …
Citations:23
Authors: G Mountzios, MA Dimopoulos, A Bamias, G Vourli, H Kalofonos, ...
Publication: Annals of oncology 20 (8), 1362-1368

95. Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group
Citations:23
Authors: G Fountzilas, G Stathopoulos, C Nicolaides, A Kalogera-Fountzila, ...
Publication: Annals of oncology 10 (4), 475-478

101. Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2-and ER-negative breast cancer
Citations:20
Authors: M Ihnen, RM Wirtz, KT Kalogeras, K Milde-Langosch, M Schmidt, I Witzel, ...
Publication: British journal of cancer 103 (7), 1048

103. A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer
Citations:19
Authors: W Janni, T Sarosiek, B Karaszewska, J Pikiel, E Staroslawska, P Potemski, ...
Publication: Breast cancer research and treatment 143 (3), 493-505

104. Prognostic significance of phosphorylated STAT‐1 expression in premenopausal and postmenopausal patients with invasive breast cancer
Citations:19
Authors: C Magkou, I Giannopoulou, I Theohari, A Fytou, P Rafailidis, A Nomikos, ...
Publication: Histopathology 60 (7), 1125-1132

108. Systemic chemotherapy with pemetrexed and cisplatin for malignant peritoneal mesothelioma: a single institution experience
Citations:18
Authors: G Lainakis, F Zagouri, E Kastritis, TN Sergentanis, G Bozas, ...
Publication: Tumori Journal 97 (1), 25-29

109. Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer: a Hellenic Cooperative Oncology Group (HeCOG) study
Citations:18
Authors: G Aravantinos, G Fountzilas, A Bamias, I Grimani, S Rizos, HP Kalofonos, ...
Publication: European Journal of Cancer 44 (15), 2169-2177

110. A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: A Hellenic …
Citations:18
Authors: HP Kalofonos, A Bamias, A Koutras, P Papakostas, G Basdanis, ...
Publication: European Journal of Cancer 44 (12), 1693-1700

112. Does pregnancy-associated breast cancer imply a worse prognosis? A matched case-case study
Citations:17
Authors: C Dimitrakakis, F Zagouri, A Tsigginou, S Marinopoulos, TN Sergentanis, ...
Publication: Breast Care 8 (3), 203-207

113. Advanced epithelial ovarian cancer in the elderly: chemotherapy tolerance and outcome
Citations:17
Authors: E Efstathiou, MA Dimopoulos, G Bozas, E Kastritis, LA Moulopoulos, ...
Publication: Anticancer research 27 (1B), 611-617

117. Burkitt’s lymphoma in pregnancy with bilateral breast involvement: case report with review of the literature
Citations:15
Authors: P Savvari, C Matsouka, D Barbaroussi, D Christoulas, N Nikitas, ...
Publication: Oncology Research and Treatment 33 (8-9), 461-464

120. Thermal heterogeneity constitutes a marker for the detection of malignant gastric lesions in vivo
Citations:15
Authors: C Stefanadis, C Chrysohoou, E Paraskevas, DB Panagiotakos, ...
Publication: Journal of clinical gastroenterology 36 (3), 215-218

121. A multicenter randomized trial of paclitaxel (175 mg/m2) plus carboplatin (6AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6AUC) in advanced non-small cell lung cancer …
Citations:15
Authors: PA Kosmidis, N Mylonakis, D Skarlos, E Samantas, MA Demopoulos, ...
Publication: European Journal of Cancer 35, S247

122. Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas?
Citations:14
Authors: N Thomakos, A Rodolakis, F Zagouri, D Zacharakis, M Sotiropoulou, ...
Publication: Archives of gynecology and obstetrics 287 (1), 97-102

123. Paclitaxel chemotherapy and vascular toxicity as assessed by flow-mediated and nitrate-mediated vasodilatation
Citations:14
Authors: M Vassilakopoulou, G Mountzios, C Papamechael, AD Protogerou, ...
Publication: Vascular pharmacology 53 (3-4), 115-121

130. Potential role of the alcohol and smoking in the squamous cell carcinoma of the head and neck: review of the current literature and new perspectives
Citations:13
Authors: A Zygogianni, G Kyrgias, K Mystakidou, C Antypas, J Kouvaris, ...
Publication: Asian Pac J Cancer Prev 12 (2), 339-44

132. Giant cell arteritis of the breast and breast cancer: paraneoplastic manifestation or concomitant disease? A case report
Citations:13
Authors: E Kafantari, M Sotiropoulou, P Sfikakis, K Dimitrakakis, F Zagouri, ...
Publication: Oncology Research and Treatment 31 (12), 685-688

135. Prophylactic mastectomy: an appraisal
Citations:12
Authors: F Zagouri, DT Chrysikos, TN Sergentanis, G Giannakopoulou, ...
Publication: The American Surgeon 79 (2), 205-212

138. Haplotype analysis reveals that the recurrent BRCA1 deletion of exons 23 and 24 is a Greek founder mutation
Citations:11
Authors: P Apostolou, M Pertesi, V Aleporou‐Marinou, C Dimitrakakis, ...
Publication: Clinical genetics 91 (3), 482-487

139. Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trial
Citations:11
Authors: G Fountzilas, V Kotoula, D Pectasides, G Kouvatseas, E Timotheadou, ...
Publication: PloS one 8 (7), e69256

140. HTERT MNS16A polymorphism in breast cancer: a case–control study
Citations:11
Authors: F Zagouri, TN Sergentanis, M Gazouli, A Tsigginou, C Dimitrakakis, ...
Publication: Molecular biology reports 39 (12), 10859-10863

146. alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies
Citations:10
Authors: T Koletsa, F Stavridi, M Bobos, I Kostopoulos, V Kotoula, AG Eleftheraki, ...
Publication: BMC clinical pathology 14 (1), 28

149. Endovascular stenting for the management of port-a-cath associated superior vena cava syndrome
Citations:10
Authors: V Kostopoulou, ML Tsiatas, DA Kelekis, MA Dimopoulos, ...
Publication: Emergency radiology 16 (2), 143-146

151. Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer
Citations:10
Authors: G Fountzilas, D Pectasides, C Christodoulou, E Timotheadou, ...
Publication: Medical Oncology 23 (4), 479-488

156. Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study …
Citations:8
Authors: J Gligorov, B Ataseven, M Verrill, M De Laurentiis, KH Jung, HA Azim, ...
Publication: European Journal of Cancer 82, 237-246

158. Serum MMPs and TIMPs: May be predictors of breast carcinogenesis?
Citations:8
Authors: F Zagouri, TN Sergentanis, E Kalogera, X Provatopoulou, D Chrysikos, ...
Publication: Clinica Chimica Acta 412 (7-8), 537-540

161. Adjuvant chemotherapy with paclitaxel and carboplatin in non-endometrioid carcinoma of the uterus.
Citations:8
Authors: GT Bozas, A Bamias, E Kastritis, A Rodolakis, G Vlahos, ...
Publication: European journal of gynaecological oncology 26 (6), 627-631

164. Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.
Citations:7
Authors: S Karageorgopoulou, ID Kostakis, M Gazouli, S Markaki, M Papadimitriou, ...
Publication: BMC cancer 17 (1), 451

165. Breast cancer in women aged 25 years and younger
Citations:7
Authors: C Dimitrakakis, A Tsigginou, F Zagouri, S Marinopoulos, TN Sergentanis, ...
Publication: Obstetrics & Gynecology 121 (6), 1235-1240

166. Serum levels of HSP90 in the continuum of breast ductal and lobular lesions
Citations:7
Authors: F Zagouri, TN Sergentanis, X Provatopoulou, E Kalogera, D Chrysikos, ...
Publication: In Vivo 25 (4), 669-672

169. Protein expression patterns of cell cycle regulators in operable breast cancer
Citations:6
Authors: F Zagouri, V Kotoula, G Kouvatseas, M Sotiropoulou, T Koletsa, ...
Publication: PloS one 12 (8), e0180489

171. Untreated newly diagnosed essential hypertension is associated with nonalcoholic fatty liver disease in a population of a hypertensive center
Citations:6
Authors: S Michopoulos, VI Chouzouri, ED Manios, E Grapsa, Z Antoniou, ...
Publication: Clinical and experimental gastroenterology 9, 1

172. Final overall survival analysis of a phase II trial evaluating vinorelbine and lapatinib in women with ErbB2 overexpressing metastatic breast cancer
Citations:6
Authors: W Janni, T Sarosiek, B Karaszewska, J Pikiel, E Staroslawska, P Potemski, ...
Publication: The Breast 24 (6), 769-773

173. Adjuvant chemotherapy and acute toxicity in hypofractionated radiotherapy for early breast cancer
Citations:6
Authors: V Kouloulias, A Zygogianni, E Kypraiou, J Georgakopoulos, ...
Publication: World Journal of Clinical Cases: WJCC 2 (11), 705

174. Consolidation Therapy with Bortezomib, Thalidomide and Dexamethasone (VTD) Regimen After ASCT in Myeloma Patients Who Do Not Receive Bisphosphonates Reduces Bone Resorption and …
Citations:6
Authors: E Terpos, D Christoulas, M Migkou, M Gavriatopoulou, A Papatheodorou, ...
Publication: Blood 114 (22), 3863-3863

175. Late relapse of epithelial ovarian cancer: a single institution experience.
Citations:6
Authors: A Bamias, E Efstathiou, M Vassilakopoulou, V Koutsoukou, ...
Publication: European journal of gynaecological oncology 26 (4), 439-442

178. Human TAU P301L overexpression results in TAU hyperphosphorylation without neurofibrillary tangles in adult zebrafish brain
Citations:5
Authors: MI Cosacak, P Bhattarai, L Bocova, T Dzewas, V Mashkaryan, ...
Publication: Scientific Reports 7 (1), 12959

179. Tumor infiltrating lymphocytes affect the outcome of patients with operable triple-negative breast cancer in combination with mutated amino acid classes
Citations:5
Authors: V Kotoula, S Lakis, IS Vlachos, E Giannoulatou, F Zagouri, Z Alexopoulou, ...
Publication: PloS one 11 (9), e0163138

180. Gestational trophoblastic neoplasia with retroperitoneal metastases: a fatal complication
Citations:5
Authors: N Thomakos, A Rodolakis, P Belitsos, F Zagouri, I Chatzinikolaou, ...
Publication: World journal of surgical oncology 8 (1), 114

182. Treatment of advanced pancreatic cancer with docetaxel: A multicenter phase II study
Citations:5
Authors: C Kouroussis, S Kakolyris, G Samelis, G Aravantinos, AM Dimopoulos, ...
Publication: PROCEEDINGS OF THE ANNUAL MEETING-AMERICAN SOCIETY OF CLINICAL ONCOLOGY 17 …

183. Very late relapse of Hodgkin's disease after 24 years of complete remission
Citations:5
Authors: MA Dimopoulos, E Kostis, A Anagnostopoulos, M Dalezios, ...
Publication: Leukemia & lymphoma 28 (1-2), 215-217

186. The prognostic value of the immunohistochemical expression of phosphorylated RB and p16 proteins in association with cyclin D1 and the p53 pathway in a large cohort of patients …
Citations:4
Authors: T Gavressea, KT Kalogeras, GA Koliou, F Zagouri, G Lazaridis, H Gogas, ...
Publication: Anticancer research 37 (6), 2947-2957

187. A retrospective analysis of toxicity and efficacy for 2 hypofractionated irradiation schedules versus a conventional one for post-mastectomy adjuvant radiotherapy in breast cancer
Citations:4
Authors: V Kouloulias, E Mosa, A Zygogianni, E Kypraiou, J Georgakopoulos, ...
Publication: Breast Care 11 (5), 328-332

189. MMP-2− 1306C> T polymorphism in breast cancer: a case–control study in a South European population
Citations:4
Authors: F Zagouri, TN Sergentanis, M Gazouli, C Dimitrakakis, A Tsigginou, ...
Publication: Molecular biology reports 40 (8), 5035-5040

190. Non-blood medical care in gynecologic oncology: a review and update of blood conservation management schemes
Citations:4
Authors: M Simou, N Thomakos, F Zagouri, A Vlysmas, N Akrivos, D Zacharakis, ...
Publication: World journal of surgical oncology 9 (1), 142

194. Correlation of MYC gene and protein status with breast cancer subtypes and outcome of patients treated with anthracycline-based adjuvant chemotherapy. Pooled analysis of 2 …
Citations:3
Authors: A Batistatou, V Kotoula, M Bobos, G Kouvatseas, F Zagouri, E Tsolaki, ...
Publication: Clinical breast cancer 18 (1), 53-62. e3

198. Relapse of ovarian cancer with bone marrow infiltration and concurrent emergence of therapy-related acute myeloid leukemia: a case report
Citations:3
Authors: D Christoulas, C Matsouka, I Chatzinikolaou, D Barmparoussi, ...
Publication: Journal of Clinical Oncology 29 (11), e295-e296

200. Excisional breast biopsy under local anesthesia: stress-related neuroendocrine, metabolic and immune reactions during the procedure
Citations:3
Authors: GC Zografos, F Zagouri, TN Sergentanis, G Giannakopoulou, ...
Publication: in vivo 23 (4), 649-652

203. Docetaxel and cisplatin (DC) combination chemotherapy for metastatic urothelial cancer
Citations:3
Authors: M Dimopoulos, G Louras, D Pantazopoulos, C Deliveliotis, ...
Publication: European Journal of Cancer 33 (S8), S35-S35

207. Abiraterone Acetate withdrawal in selected m CRPC patients
Citations:2
Authors: E Bournakis
Publication: bone 8 (4), 36

208. VTD CONSOLIDATION, WITHOUT BISPHOSPHONATES, REDUCES BONE RESORPTION AND IS ASSOCIATED WITH A VERY LOW INCIDENCE OF SKELETAL-RELATED EVENTS IN PATIENTS WITH MULTIPLE MYELOMA …
Citations:2
Authors: E Terpos, D Christoulas, E Kastritis, M Roussou, M Migkou, ...
Publication: HAEMATOLOGICA 98, 330-330

210. A woman with breast cancer and severe impaired lactose tolerance: an intriguing therapeutic dilemma
Citations:2
Authors: F Zagouri, C Dimitrakakis, MA Dimopoulos, A Tsigginou, A Antsaklis, ...
Publication: The breast journal 18 (6), 628-629

212. Evaluation of the prognostic value of UBE2C mRNA levels in early breast cancer.
Citations:2
Authors: D Psyrri, R Kronenwett, E Timotheadou, RM Wirtz, A Onyenadum, ...
Publication: Journal of Clinical Oncology 28 (15_suppl), 10570-10570

214. Salvage therapy in heavily pretreated ovarian cancer with single agent pegylated liposomal doxorubicin (PLD): Preliminary results of a multicenter phase II study of the …
Citations:2
Authors: H Linardou, G Aravantinos, D Bafaloukos, D Skarlos, H Kalofonos, ...
Publication: Annals of Oncology 11

215. A multicenter randomized phase III study of paclitaxel (175 mg/m (2)) plus carboplatin (AUC 6) versus paclitaxel (225 mg/m (2)) plus carboplatin (AUC 6) in advanced non-small …
Citations:2
Authors: DV Skarlos, N Mylonakis, G Fountzilas, E Samantas, MA Dimopoulos, ...
Publication: SEMINARS IN ONCOLOGY 26 (6), 25-25

216. PALB2 c. 2257C> T truncating variant is a Greek founder and is associated with high breast cancer risk
Citations:1
Authors: A Vagena, M Papamentzelopoulou, D Kalfakakou, P Kollia, ...
Publication: Journal of human genetics, 1

217. Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer
Citations:1
Authors: E Fountzilas, V Kotoula, G Pentheroudakis, K Manousou, ...
Publication: ESMO open 4 (2), e000474

220. Contribution of RAD51D germline mutations in breast and ovarian cancer in Greece
Citations:1
Authors: I Konstanta, F Fostira, P Apostolou, E Stratikos, D Kalfakakou, ...
Publication: Journal of human genetics 63 (11), 1149

221. 1845P Safety, clinical activity and pharmacological biomarker evaluation of the DNA-dependent protein kinase (DNA-PK) inhibitor M3814: Results from two phase I trials
Citations:1
Authors: M Mau-Sorensen, M van Bussel, M Kuipers, DL Nielsen, HM Verheul, ...
Publication: Annals of Oncology 29 (suppl_8), mdy303. 015

222. Phase 2 study of eribulin mesylate in combination with carboplatin in patients with advanced triple-negative breast cancer.
Citations:1
Authors: V Michalaki, E Karvouni, N Dafnios, C Psychogios, J Vasiliou, ...
Publication: Journal of Clinical Oncology 34 (15_suppl), e12551-e12551

223. Accuracy of frozen section in the diagnosis of mucinous ovarian tumors
Citations:1
Authors: A Tranoulis, N Thomakos, D Haidopoulos, M Sotiropoulou, N Kathopoulis, ...
Publication: Gynecologic Oncology 137, 109

227. Abstract P5-18-21: A Phase II randomized trial of lapatinib with either vinorelbine or capecitabine as first-and second-line therapy for ErbB2-overexpressing metastatic breast …
Citations:1
Authors: W Janni, T Sarosiek, J Pikiel, B Karaszewska, E Staroslawska, C Salat, ...
Publication: Cancer Research 72 (24 Supplement), P5-18-21-P5-18-21

228. Randomized, phase III study of carboplatin plus paclitaxel for 8 cycles (CP8) versus carboplatin x 8 cycles plus paclitaxel x 4 cycles (C8P4) in advanced ovarian, fallopian, or …
Citations:1
Authors: A Bamias, E Timotheadou, G Aravantinos, DG Pectasides, ...
Publication: Journal of Clinical Oncology 30 (15_suppl), 5033-5033

229. PD05-02: Effect of HER2/Topoisomerase II alpha (TOP2A) Gene Status or Protein Expression and Chromosome 17 (CEP17) Polysomy on the Outcome of Breast Cancer Patients Treated …
Citations:1
Authors: U Dafni, M Bobos, E Tsolaki, A Batistatou, F Koletsa, D Televantou, ...
Publication: Cancer Research 71 (24 Supplement), PD05-02-PD05-02

233. Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer
Citations:1
Authors: HP Kalofonos, P Papakostas, T Makatsoris, D Papamichael, G Vourli, ...
Publication: Anticancer research 30 (10), 4325-4333

236. The Impact of Different Pre-Transplant Regimens Including Novel Agents On Peripheral Blood Mobilization, Harvest, Response and Survival in Patients Undergoing ASCT for Multiple …
Citations:1
Authors: E Eleutherakis-Papaiakovou, D Christoulas, M Migkou, M Gavriatopoulou, ...
Publication: Blood 114 (22), 2279-2279

237. Safety results of a phase III randomized trial of adjuvant treatment with 5-fluorouracil and folinic acid with or without irinotecan, in Dukes B2 and C colon cancer
Citations:1
Authors: P Papakostas, HP Kalofonos, G Pentheroudakis, E Timotheadou, ...
Publication: Journal of Clinical Oncology 25 (18_suppl), 4053-4053

240. Outcome of elderly patients following platinum-based chemotherapy for advanced urothelial cancer
Citations:1
Authors: A Bamias, E Efstathiou, G Hamilos, P Zorzou, G Bozas, D Gika, ...
Publication: Journal of Clinical Oncology 22 (14_suppl), 4542-4542

241. Outcome of elderly patients following platinum-based chemotherapy for advanced urothelial cancer
Citations:1
Authors: A Bamias, E Efstathiou, G Hamilos, P Zorzou, G Bozas, D Gika, ...
Publication: Journal of Clinical Oncology 22 (14_suppl), 4542-4542

243. Helicobacter pylori infection among patients with alcoholic and non-alcoholic cirrhosis
Citations:1
Authors: C Liatsos, K Petraki, V Xiromeritou, N Sfouggatakis, G Oikonoraou, ...
Publication: Gastroenterology 118 (4), A1267

245. Combination paclitaxel plus carboplatin versus paclitaxel with alternating carboplatin and cisplatin as first line treatment for advanced ovarian cancer (AOC)
Citations:1
Authors: G Aravantinos, G Fountzilas, P Kosmides, GP Stathopoulos, N Pavlidis, ...
Publication: ANNALS OF ONCOLOGY 9, 66-66

247. Epidemiological characteristics, clinical outcomes and management patterns of metastatic breast cancer patients in routine clinical care settings of Greece: Results from the …
Citations:
Authors: A Kotsakis, A Ardavanis, G Koumakis, E Samantas, A Psyrri, ...
Publication: BMC cancer 19 (1), 88

249. One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene
Citations:
Authors: F Fostira, I Kostantopoulou, P Apostolou, MS Papamentzelopoulou, ...
Publication: Journal of medical genetics, jmedgenet-2019-106189

250. Combination of germline and tumor testing yields a high rate of loss-of-function variants in non-mucinous epithelial ovarian cancer patients
Citations:
Authors: F Fostira, D Kalfakakou, MS Papamentzelopoulou, A Delimitsou, ...
Publication: Cancer Research 79 (13 Supplement), 4170-4170

251. P-142 Sunitinib rechallenge in pancreatic neuroendocrine tumors
Citations:
Authors: V Michalaki, A Poydorou, G Frangulidis, A Vezakis, T Theodosopoulos, ...
Publication: Annals of Oncology 30 (Supplement_4), mdz155. 141

252. Novel treatment planning approaches to enhance the therapeutic ratio: targeting the molecular mechanisms of radiation therapy
Citations:
Authors: M Protopapa, V Kouloulias, A Kougioumtzopoulou, Z Liakouli, ...
Publication: Clinical and Translational Oncology, 1-10

254. Microsatellite instability and mutations in BRAF and KRAS in small bowel adenocarcinoma.
Citations:
Authors: V Michalaki, A Polydorou, T Theodosopoulos, G Frangulidis, N Dafnios, ...
Publication: Journal of Clinical Oncology 37 (15_suppl), e15037-e15037

255. ENGOT-OV44/FIRST study: A randomized, double-blind, adaptive, phase III study of platinum-based therapy with dostarlimab (TSR-042)+ niraparib versus standard-of-care (SOC …
Citations:
Authors: AC Hardy-Bessard, KN Moore, MR Mirza, B Asselain, A Redondo, ...
Publication: Journal of Clinical Oncology 37 (15_suppl), TPS5600-TPS5600

257. Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer
Citations:
Authors: DI Lampropoulou, G Aravantinos, H Katifelis, F Lazaris, K Laschos, ...
Publication: Cancer Biomarkers, 1-9

259. Assessing the landscape of ovarian serous borderline tumors
Citations:
Authors: I Messini, T Doulgeraki, D Chrysanthakis, P Yiannou, T Gavresea, ...
Publication: International Journal of Gynecologic Cancer 29 (3), 572-578

262. Actionable mutations and overall survival in 3,211 patients with cancer: The Hellenic cooperative oncology group precision medicine initiative
Citations:
Authors: E Fountzila, V Kotoula, GA Koliou, E Giannoulatou, H Gogas, ...
Publication: ANNALS OF ONCOLOGY 29, 664-664

263. Prognostic implications of mismatch repair deficiency in patients with early-stage colorectal and endometrial cancer
Citations:
Authors: E Fountzila, V Kotoula, G Pentherdoudakis, K Manousou, E Vrettou, ...
Publication: ANNALS OF ONCOLOGY 29, 654-654

264. 1844P Prognostic implications of mismatch repair deficiency in patients with early-stage colorectal and endometrial cancer
Citations:
Authors: E Fountzila, V Kotoula, G Pentherdoudakis, K Manousou, E Vrettou, ...
Publication: Annals of Oncology 29 (suppl_8), mdy303. 014

265. 569P ISO-CC-005; A phase I/II study of arfolitixorin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin±bevacizumab in patients with metastasizing colorectal cancer
Citations:
Authors: GU Carlsson, TK Guren, J Haux, P Pfeiffer, H Taflin, D Mavroudis, ...
Publication: Annals of Oncology 29 (suppl_8), mdy281. 115

266. 1877P DNA repair genetic profiling in epithelial ovarian cancer: An opportunity for clinical improvement?
Citations:
Authors: J Assis, S Coelho, A Nogueira, R Pinto, M Brandao, J Dias, S Alves, ...
Publication: Annals of Oncology 29 (suppl_8), mdy303. 047

267. 1876P Actionable mutations and overall survival in 3,211 patients with cancer: The Hellenic cooperative oncology group precision medicine initiative
Citations:
Authors: E Fountzila, V Kotoula, GA Koliou, E Giannoulatou, H Gogas, ...
Publication: Annals of Oncology 29 (suppl_8), mdy303. 046

268. Gemcitabine/nabpaclitaxel efficacy in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma
Citations:
Authors: V Michalaki, A Polydorou, G Frangulidis, A Vezakis, E Karvouni, ...
Publication: ANNALS OF ONCOLOGY 29, 44-44

269. Immunohistochemical study of KRAS, NRAS, BRAF and MSI phenotype in Small Bowel adenocarcinoma.
Citations:
Authors: V Michalaki, G Frangulidis, A Polydorou, T Theodosopoulos, A Vezakis, ...
Publication: ANNALS OF ONCOLOGY 29, 6-6

270. P-157 Gemcitabine/nabpaclitaxel efficacy in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma
Citations:
Authors: V Michalaki, A Poydorou, G Frangulidis, A Vezakis, E Karvouni, ...
Publication: Annals of Oncology 29 (suppl_5), mdy151. 156

271. P-020 Immunohistochemical study of KRAS, NRAS, BRAF and MSI phenotype in small bowel adenocarcinoma
Citations:
Authors: V Michalaki, G Frangulidis, A Poydorou, T Theodosopoulos, A Vezakis, ...
Publication: Annals of Oncology 29 (suppl_5), mdy151. 019

272. Assesment of cardiac effects of ado-trastuzumab emtansine through strain rate imaging in metastatic breast cancer.
Citations:
Authors: V Michalaki, G Koutroulis, I Kontis, G Frangulidis, N Dafnios, E Karvouni, ...
Publication: Journal of Clinical Oncology 36 (15_suppl), e13007-e13007

273. Low circulating mannan-binding lectin levels correlate with increased frequency and severity of febrile episodes in myeloma patients who undergo ASCT and do not receive …
Citations:
Authors: E Eleutherakis-Papaiakovou, MA Dimopoulos, E Kastritis, D Christoulas, ...
Publication: Bone marrow transplantation 52 (11), 1537

274. 296PDetection of early cardiac effects of docetaxel plus trastuzumab and pertuzumab through strain rate imaging in patients with HER2-positive metastatic breast cancer
Citations:
Authors: V Michalaki, G Koutroulis, I Psychogios, E Karvouni, I Vasiliou, ...
Publication: Annals of Oncology 28 (suppl_5)

275. 824PARV7 status and CTC count: A combined biomarker for the baseline therapeutic decision in each line of mCRPC treatment
Citations:
Authors: E Bournakis, E Lianidou, A Strati, M Zavridou, A Sfika, A Bournakis, ...
Publication: Annals of Oncology 28 (suppl_5)

276. P-212Gemcitabine plus capecitabine in elderly patients with advanced pancreatic cancer
Citations:
Authors: V Michalaki, A Poydorou, A Vezakis, G Frangulidis, T Theodosopoulos, ...
Publication: Annals of Oncology 28 (suppl_3)

277. Safety and efficacy of eribulin in combination with gemcitabine in patients with advanced triple negative breast cancer.
Citations:
Authors: V Michalaki, G Fragulidis, I Kondis, E Karvouni, N Dafnios, A Kotsiou, ...
Publication: Journal of Clinical Oncology 35 (15_suppl), e12578-e12578

278. Rationale and design of the real-world Hellenic disease management patterns with everolimus for women with hormone-receptor-positive, human epidermal growth factor ReceptOR-2 …
Citations:
Authors: C Karanikiotis, G Kesisis, I Xanthakis, A Alexopoulos, V Barbounis, ...
Publication: The Breast 32, S69

280. P-013Prognostic significance of cyclin D1 and p21 (WAF1/CIP1) in Gastric Cancer
Citations:
Authors: V Michalaki, T Theodosopoulos, N Dafnios, A Vezakis, E Karvouni, ...
Publication: Annals of Oncology 27 (Suppl 2), ii4

281. Platinum-based therapy in heavily pretreated m CRPC patients
Citations:
Authors: E Bournakis
Publication: bone 8 (30), 71

282. 2217 The role of cyclin D1 and p21 (WAF1/CIP1) in gastric cancer
Citations:
Authors: V Michalaki, G Frangulidis, A Kondi-Pafgiti, J Papakonstandinou, ...
Publication: European Journal of Cancer 51, S405

283. Safety and efficacy of eribulin as second-line treatment for HER2-negative metastatic breast cancer.
Citations:
Authors: V Michalaki, J Psychogios, J Contis, A Kondi, C Gennatas, ...
Publication: Journal of Clinical Oncology 33 (15_suppl), e11583-e11583

286. The Role of Paclitaxel Albumin-Stabilized Nanoparticle Formulation (Nab-Paclitaxel) in the Treatment of Breast Cancer: A Short Review
Citations:
Authors: M Liontos, E Eleutherakis-Papaiakovou, K Koutsoukos, F Zagouri, ...
Publication: Global Journal of Breast Cancer Research 1 (1), 36-42

288. PharmaNews/PharmaTicker
Citations:
Authors: M Kipling, C Christou, L Barthelmes, M Gumus, H Gumus, SE Jones, ...
Publication: Breast Care 8 (3), 237-237

289. Vol. 8, Issue 3, June 2013/Band 8, Heft 3, Juni 2013
Citations:
Authors: M Kipling, C Christou, L Barthelmes, M Gumus, H Gumus, SE Jones, ...
Publication: Breast Care 8 (3), 170-171

290. Contents of Forthcoming Issues· Themenvorschau
Citations:
Authors: M Kipling, C Christou, L Barthelmes, M Gumus, H Gumus, SE Jones, ...
Publication: Breast Care 8 (3), 240-240

291. Mitteilungen· Reports
Citations:
Authors: M Kipling, C Christou, L Barthelmes, M Gumus, H Gumus, SE Jones, ...
Publication: Breast Care 8 (3), 234-236

292. Imprint
Citations:
Authors: M Kipling, C Christou, L Barthelmes, M Gumus, H Gumus, SE Jones, ...
Publication: Breast Care 8 (3), 233-233

293. ESR1 gene amplification and protein expression in 946 patients with resected breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) translational research study.
Citations:
Authors: GE Pentheroudakis, A Batistatou, U Dafni, M Bobos, E Tsolaki, V Kotoula, ...
Publication: Journal of Clinical Oncology 30 (15_suppl), 592-592

295. Mobilization of autologous peripheral blood stem cells with Spectra Optia v5. 0: a single-centre experience with an automatic interface-controlled apheresis system
Citations:
Authors: E Eleutherakis-Papaiakovou, E Terpos, E Kastritis, D Christoulas, ...
Publication: Bone Marrow Transplantation 47

296. Low circulating Mmannan-binding leptin levels correlate with increased number of febrile episodes in myeloma patients who undergo high-dose melphalan with autologous …
Citations:
Authors: E Eleutherakis-Papaiakovou, E Terpos, D Christoulas, M MIgkou, ...
Publication: Bone Marrow Transplantation 47

299. Vol. 35, Issue 3, March 2012/Band 35, Heft 3, März 2012
Citations:
Authors: W Kuhn, F Hilpert, P Wimberger, A du Bois, J Pfisterer, P Harter, K Kim, ...
Publication: Oncology Research and Treatment 35 (3), 66-68

300. PharmaForum
Citations:
Authors: W Kuhn, F Hilpert, P Wimberger, A du Bois, J Pfisterer, P Harter, K Kim, ...
Publication: Oncology Research and Treatment 35 (3), 141-142

301. Contents of Forthcoming Issues· Themenvorschau
Citations:
Authors: W Kuhn, F Hilpert, P Wimberger, A du Bois, J Pfisterer, P Harter, K Kim, ...
Publication: Oncology Research and Treatment 35 (3), 152-152

302. Mitteilungen onkologischer Gesellschaften· Reports of Oncological Societies
Citations:
Authors: W Kuhn, F Hilpert, P Wimberger, A du Bois, J Pfisterer, P Harter, K Kim, ...
Publication: Oncology Research and Treatment 35 (3), 140-140

303. Imprint
Citations:
Authors: W Kuhn, F Hilpert, P Wimberger, A du Bois, J Pfisterer, P Harter, K Kim, ...
Publication: Oncology Research and Treatment 35 (3), 117-117

304. PharmaNews/PharmaTicker
Citations:
Authors: W Kuhn, F Hilpert, P Wimberger, A du Bois, J Pfisterer, P Harter, K Kim, ...
Publication: Oncology Research and Treatment 35 (3), 143-145

305. Quiz Case: A 19-Year-Old Woman with Hypercalcemia and Abdominal Pain
Citations:
Authors: F Zagouri, N Thomakos, A Rodolakis, A Bamias, A Chalazonitis, ...
Publication: Oncology Research and Treatment 35 (3), 126-127

308. Low Circulating Mannan-Binding Leptin Levels Correlate with Increased Number of Febrile Episodes in Myeloma Patients Who Undergo High Dose Melphalan with Autologous …
Citations:
Authors: E Eleutherakis-Papaiakovou, E Terpos, D Christoulas, M Migkou, ...
Publication: Blood 118 (21), 4457-4457

309. Mobilization of Autologous Peripheral Blood Stem Cells with Spectra Optia v5. 0: A Single Center Experience with An Automatic Interface-Controlled Apheresis System
Citations:
Authors: E Eleutherakis-Papaiakovou, E Terpos, E Kastritis, D Christoulas, ...
Publication: Blood 118 (21), 4396-4396

313. Mutations of exon 1 and exon 2 of beta-catenin gene in invasive breast carcinomas
Citations:
Authors: L Nakopoulou, I Theohari, I Giannopoulou, C Magkou, P Rafailidis, ...
Publication: VIRCHOWS ARCHIV 459, S6-S6

318. P154 Diagnosis of breast cancer during pregnancy: A five year experience
Citations:
Authors: C Dimitrakakis, A Tsigginou, F Zagouri, T Sergentanis, S Marinopoulos, ...
Publication: The Breast 20, S31

319. P115 Decreased Hsp90 expression in the continuum of breast lobular lesions
Citations:
Authors: F Zagouri, T Sergentanis, A Nonni, D Chrysikos, G Bletsa, I Flessas, ...
Publication: The Breast 20, S20-S21

320. Guidelines for Authors
Citations:
Authors: E Muhl, WH Hartl, FG Bader, A Frank, UJ Roblick, T Jungbluth, ...
Publication: Visceral Medicine 27 (1), 96-96

321. Vol. 34, Issue 3, March 2011/Band 34, Heft 3, Marz 2011
Citations:
Authors: B Lawrenz, T Fehm, E Neunhoeffer, B Krämer, M Soekler, L Kanz, ...
Publication: Oncology Research and Treatment 34 (3), 82-83

322. Guidelines for Authors
Citations:
Authors: B Lawrenz, T Fehm, E Neunhoeffer, B Krämer, M Soekler, L Kanz, ...
Publication: Oncology Research and Treatment 34 (3), 151-151

323. Imprint
Citations:
Authors: B Lawrenz, T Fehm, E Neunhoeffer, B Krämer, M Soekler, L Kanz, ...
Publication: Oncology Research and Treatment 34 (3), 138-138

324. Contents of Forthcoming Issues· Themenvorschau
Citations:
Authors: B Lawrenz, T Fehm, E Neunhoeffer, B Krämer, M Soekler, L Kanz, ...
Publication: Oncology Research and Treatment 34 (3), 152-152

325. PharmaNews/PharmaTicker
Citations:
Authors: B Lawrenz, T Fehm, E Neunhoeffer, B Krämer, M Soekler, L Kanz, ...
Publication: Oncology Research and Treatment 34 (3), 147-148

330. Effects of Rosuvastatin and Allopurinol on Endothelial Progenitor Cells in Patients With Chronic Heart Failure: The Role of Inflammation and Oxidative Stress
Citations:
Authors: I Andreou, D Tousoulis, C Tentolouris, M Tsiatas, G Siasos, ...
Publication: Circulation 122 (suppl_21), A20953-A20953

331. Effects of Rosuvastatin and Allopurinol on Endothelial Progenitor Cells in Patients With Chronic Heart Failure: The Role of Inflammation and Oxidative Stress
Citations:
Authors: I Andreou, D Tousoulis, C Tentolouris, M Tsiatas, G Siasos, ...
Publication: Circulation 122 (suppl_21), A20953-A20953

333. Abstract 20953
Citations:
Authors: I Andreou, D Tousoulis, C Tentolouris, M Tsiatas, G Siasos, ...
Publication: Circulation 122 (21_MeetingAbstracts)

335. Mitteilungen onkologischer Gesellschaften· Reports of Oncological Societies
Citations:
Authors: J Bladé, L Rosiñol, MT Cibeira, CF de Larrea, VR Jacobs, L Rasche, ...
Publication: Oncology Research and Treatment 33 (11), 639-641

336. Contents of Forthcoming Issues· Themenvorschau
Citations:
Authors: J Szkandera, F Ploner, T Bauernhofer, AK Kasparek, F Payer, M Balic, ...
Publication: Oncology Research and Treatment 33 (8-9), 492-492

337. Vol. 33, Issue 8-9, September 2010/Band 33, Heft 8-9, September 2010
Citations:
Authors: J Szkandera, F Ploner, T Bauernhofer, AK Kasparek, F Payer, M Balic, ...
Publication: Oncology Research and Treatment 33 (8-9), 414-415

338. ASCO 2010: Stellenwert von Sunitinib und Temsirolimus bestätigt mRCC-Patienten profitieren vonLangzeittherapie mit Sunitinib
Citations:
Authors: J Szkandera, F Ploner, T Bauernhofer, AK Kasparek, F Payer, M Balic, ...
Publication: Oncology Research and Treatment 33 (8-9), 483-483

339. Vol. 33, Issue 11, November 2010/Band 33, Heft 11, November 2010
Citations:
Authors: J Bladé, L Rosiñol, MT Cibeira, CF de Larrea, VR Jacobs, L Rasche, ...
Publication: Oncology Research and Treatment 33 (11), 570-571

340. PharmaNews/PharmaTicker
Citations:
Authors: J Szkandera, F Ploner, T Bauernhofer, AK Kasparek, F Payer, M Balic, ...
Publication: Oncology Research and Treatment 33 (8-9), 487-489

341. Mitteilungen onkologischer Gesellschaften Reports of Oncological Societies
Citations:
Authors: J Szkandera, F Ploner, T Bauernhofer, AK Kasparek, F Payer, M Balic, ...
Publication: Oncology Research and Treatment 33 (8-9), 481-481

342. PharmaNews/PharmaTicker
Citations:
Authors: J Bladé, L Rosiñol, MT Cibeira, CF de Larrea, VR Jacobs, L Rasche, ...
Publication: Oncology Research and Treatment 33 (11), 642-642

343. NSCLC: Tumor histologisch typisieren und individuell behandeln
Citations:
Authors: J Szkandera, F Ploner, T Bauernhofer, AK Kasparek, F Payer, M Balic, ...
Publication: Oncology Research and Treatment 33 (8-9), 482-482

344. Leptomeningeale Metastasen bei hämatologischen Neoplasien: Liposomales Cytarabin zeigt hohes Potenzial zur Therapieoptimierung
Citations:
Authors: J Szkandera, F Ploner, T Bauernhofer, AK Kasparek, F Payer, M Balic, ...
Publication: Oncology Research and Treatment 33 (8-9), 484-485

345. Contents of Forthcoming Issues· Themenvorschau
Citations:
Authors: J Bladé, L Rosiñol, MT Cibeira, CF de Larrea, VR Jacobs, L Rasche, ...
Publication: Oncology Research and Treatment 33 (11), 644-644

346. Antibacterial Prophylaxis Reduces the Incidence of Neutropenic Fever and the Rate of Infections in Patients with Multiple Myeloma Who Undergo An Autologous Stem Cell …
Citations:
Authors: E Eleutherakis-Papaiakovou, E Kostis, D Christoulas, M Migkou, ...
Publication: Blood 114 (22), 3334-3334

352. Heat shock protein90 in lobular neoplasia of the breast
Citations:
Authors: A Nonni, F Zagouri, NT Sergentanis, A Lazaris, E Patsouris, CG Zografos
Publication: VIRCHOWS ARCHIV 455, 188-188

354. Expression of STAT1 in breast cancer: relation with hormonal status and its prognostic significance
Citations:
Authors: C Magkou, A Fytou, I Giannopoulou, A Nomikos, I Theohari, ...
Publication: VIRCHOWS ARCHIV 455, 98-99

356. 0190 Réseau Romand Fertilité et Cancer (RRFC): Feasibility assessment of a fertility preservation program for young women with early stage breast cancer (EBC)
Citations:
Authors: K Zaman, M Bellavia, J Delaloye, A Ambrozetti, P Petignat, P Brioschi, ...
Publication: The Breast 18, S66

357. 0187 Weekly docetaxel with or without gemcitabine as second line chemotherapy in paclitaxel pretreated patients with metastatic breast cancer: A randomised phase II study …
Citations:
Authors: F Zagouri, A Bamias, P Papakostas, A Karadimou, E Bournakis, ...
Publication: The Breast 18, S66

359. V, Gatter KC, Harris AL, Koukourakis MI. Combined Role of Tumor Angiogenesis, bcl-2, and p53 Expression in the Prognosis of Patients With Colorectal Carcinoma. Cancer. 1999; 86 …
Citations:
Authors: A GIATROMANOLAKI, GP STATHOPOULOS, E TSIOBANOU, ...
Publication: Cancer 115 (17)

360. PharmaNews· PharmaTicker
Citations:
Authors: G von Minckwitz, M Linder, S Loibl, P Savvari, P Peitsidis, M Alevizaki, ...
Publication: Oncology Research and Treatment 32 (8-9), 532-535

361. PharmaForum
Citations:
Authors: G von Minckwitz, M Linder, S Loibl, P Savvari, P Peitsidis, M Alevizaki, ...
Publication: Oncology Research and Treatment 32 (8-9), 526-530

362. Vol. 32, Issue 8-9, September 2009
Citations:
Authors: G von Minckwitz, M Linder, S Loibl, P Savvari, P Peitsidis, M Alevizaki, ...
Publication: Oncology Research and Treatment 32 (8-9), 458-459

363. Contents of Forthcoming Issues· Themenvorschau
Citations:
Authors: G von Minckwitz, M Linder, S Loibl, P Savvari, P Peitsidis, M Alevizaki, ...
Publication: Oncology Research and Treatment 32 (8-9), 540-540

364. 8001 Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Co …
Citations:
Authors: G Mountzios, MA Dimopoulos, A Bamias, G Vourli, H Kalofonos, ...
Publication: EJC Supplements 2 (7), 450

366. A rare case of mucinous breast carcinoma of columnar cells
Citations:
Authors: N Tsoukalas, N Apostolikas, V Barbounis, G Koumakis, G Lypas, ...
Publication: Histopathology 53

368. An interesting case of a pseudomyxoma peritonei in a woman
Citations:
Authors: N Tsoukalas, N Apostolikas, G Koumakis, C Panopoulos, G Lypas, ...
Publication: Histopathology 53

374. PharmaNews
Citations:
Authors: T Schroeder, BL Viglianti, MW Dewhirst, J Ajani, M Salzberg, E Kirson, ...
Publication: Oncology Research and Treatment 31 (7), 414-415

375. PharmaNews/PharmaTicker
Citations:
Authors: M Koldehoff, A Elmaagacli, DW Beelen, B Ozturk, AO Kaya, R Yildiz, ...
Publication: Oncology Research and Treatment 31 (12), 718-720

376. PharmaForum
Citations:
Authors: M Koldehoff, A Elmaagacli, DW Beelen, B Ozturk, AO Kaya, R Yildiz, ...
Publication: Oncology Research and Treatment 31 (12), 713-717

377. Author Index Vol. 31, 2008/Autorenverzeichnis Band 31, 2008
Citations:
Authors: M Koldehoff, A Elmaagacli, DW Beelen, B Ozturk, AO Kaya, R Yildiz, ...
Publication: Oncology Research and Treatment 31 (12), 725-727

378. PharmaForum
Citations:
Authors: T Schroeder, BL Viglianti, MW Dewhirst, J Ajani, M Salzberg, E Kirson, ...
Publication: Oncology Research and Treatment 31 (7), 412-413

379. Contents of Forthcoming Issues· Themenvorschau
Citations:
Authors: M Koldehoff, A Elmaagacli, DW Beelen, B Ozturk, AO Kaya, R Yildiz, ...
Publication: Oncology Research and Treatment 31 (12), 723-723

380. Inhalt Band 31, 2008
Citations:
Authors: M Koldehoff, A Elmaagacli, DW Beelen, B Ozturk, AO Kaya, R Yildiz, ...
Publication: Oncology Research and Treatment 31 (12), IX-XIV

381. Subject Index Vol. 31, 2008
Citations:
Authors: M Koldehoff, A Elmaagacli, DW Beelen, B Ozturk, AO Kaya, R Yildiz, ...
Publication: Oncology Research and Treatment 31 (12), 728-730

382. DGHO fordert verbesserte Bedingungen für die Durchführung nicht-kommerzieller Studien
Citations:
Authors: M Koldehoff, A Elmaagacli, DW Beelen, B Ozturk, AO Kaya, R Yildiz, ...
Publication: Oncology Research and Treatment 31 (12), 710-711

383. Contents of Forthcoming Issues· Themenvorschau
Citations:
Authors: T Schroeder, BL Viglianti, MW Dewhirst, J Ajani, M Salzberg, E Kirson, ...
Publication: Oncology Research and Treatment 31 (7), 420-420

384. Sachwortverzeichnis Band 31, 2008
Citations:
Authors: M Koldehoff, A Elmaagacli, DW Beelen, B Ozturk, AO Kaya, R Yildiz, ...
Publication: Oncology Research and Treatment 31 (12), 731-733

385. Contents Vol. 31, Issue 12, December 2008
Citations:
Authors: M Koldehoff, A Elmaagacli, DW Beelen, B Ozturk, AO Kaya, R Yildiz, ...
Publication: Oncology Research and Treatment 31 (12), 646-647

386. Contents Vol. 31, Issue 7, July 2008
Citations:
Authors: T Schroeder, BL Viglianti, MW Dewhirst, J Ajani, M Salzberg, E Kirson, ...
Publication: Oncology Research and Treatment 31 (7), 354-354

391. Rapid screening of EGFR mutations in patients with non-small cell lung cancer, breast cancer and head and neck cancer treated with gefitinib on a compassionate-use program
Citations:
Authors: S Murray, E Razis, H Linardou, S Lambropoulos, E Briasoulis, D Skarlos, ...
Publication: ANNALS OF ONCOLOGY 17, 42-42

392. Detection of Her family receptor expression (mRNA) in peripheral blood of metastatic breast cancer patients treated with gefitinib
Citations:
Authors: SV Lambropoulos, S Murray, D Pectasides, DV Skarlos, HP Kalofonos, ...
Publication: ANNALS OF ONCOLOGY 17, 43-43

400. Outcome of elderly patients following platinum-based chemotherapy for advanced urothelial cancer.
Citations:
Authors: A Barnias, E Efstathiou, G Hamilos, P Zorzou, G Bozas, D Gika, ...
Publication: JOURNAL OF CLINICAL ONCOLOGY 22 (14), 392S-392S

402. GENITOURINARY CANCER-Docetaxel and Cisplatin With Granulocyte Colony-Stimulating Factor (G-CSF) Versus MVAC With G-CSF in Advanced Urothelial Carcinoma: A Multicenter …
Citations:
Authors: A Bamias, G Aravantinos, C Deliveliotis, D Bafaloukos, C Kalofonos, ...
Publication: Journal of Clinical Oncology 22 (2), 220-228

403. Combination of Pegylated Liposomal Doxorubicin (PLD) and ifosfamide (IFO) in patients with advanced soft tissue sarcoma (STS). A phase II study of the Hellenic Cooperative …
Citations:
Authors: D Bafaloukos, P Kosmidis, E Briasoulis, H Gogas, G Aravantinos, ...
Publication: ANNALS OF ONCOLOGY 15, 198-198

406. Individual DNA damage and repair following exposure to melphaian are inversely associated with clinical outcome in patients with multiple myeloma treated with high dose …
Citations:
Authors: MA Dimopoulos, PP Sfikakis, A Anagnostopoulos, G Hamilos, ...
Publication: Blood 102 (11), 982A-982A

407. Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamide.
Citations:
Authors: MA Dimopoulos, G Hamilos, A Zomas, E Efstathiou, V Grigoraki, ...
Publication: BLOOD 100 (11), 397A-397A

410. ORIGINAL REPORTS-Genitourinary Cancer-Increased Temperature of Malignant Urinary Bladder Tumors In Vivo: The Application of a New Method Based on a Catheter Technique
Citations:
Authors: C Stefanadis, C Chrysochoou, D Markou, K Petraki, DB Panagiotakos, ...
Publication: Journal of Clinical Oncology 19 (3), 676-681

413. Expression of metallothionein in colonic cancer (CC) is related to the tumor grade but not survival rate
Citations:
Authors: K Petraki, S Michopoulos, C Petraki, P Tsibouris, C Zoubouli, ...
Publication: Gastroenterology 118 (4), A1406

414. Prothymosin alpha is an accurate prognostic factor for colon cancer survival
Citations:
Authors: S Michopoulos, K Petraki, T Papamarkaki, M Economou, O Tsolas, ...
Publication: Gastroenterology 118 (4), A1400

421. Paclitaxel (175 mg/m (2)) plus carboplatin verses paclitaxel (225 mg/m (2)) plus carboplatin in inoperable non-small cell lung cancer: A randomized trial of the Hellenic …
Citations:
Authors: P Kosmidis, N Mylonakis, D Skarlos, E Samantas, M Demopoulos, ...
Publication: SEMINARS IN ONCOLOGY 26 (1), 73-73

422. LUNG CANCER-Lung Cancer Abstracts-A Multicenter Randomized Phase III Study of Paclitaxel (175 mg/m2) Plus Carboplatin (AUC 6) Versus Pactitaxel (225 mg/m2) Plus Carboplatin …
Citations:
Authors: DV Skarlos, N Mylonakis, G Fountzilas, E Samantas, MA Dimopoulos, ...
Publication: Seminars in Oncology-Supplements 26 (18), 25-25

423. ORIGINAL REPORTS-Gastrointestinal Oncology-Treatment of Pancreatic Cancer With Docetaxel and Granulocyte Colony-Simulating Factor: A Multicenter Phase II Study
Citations:
Authors: N Androulakis, C Kourousis, MA Dimopoulos, G Samelis, S Kakolyris, ...
Publication: Journal of Clinical Oncology 17 (6), 1779-1785

424. Screening for monoclonal gammopathy in a department of internal medicine: The case for benign monoclonal gammopathy?
Citations:
Authors: A Anagnostopoulos, E Evangelopoulou, D Sotou, D Gika, ...
Publication: BLOOD 92 (10), 259B-259B

437. ownership: AstraZeneca; Honoraria and consulting: AstraZeneca, BMS, Pfizer, Roche, Sanofi, Pierre Fabre. C. Massard: Other relationship: Amgen, Astellas Pharma, AstraZeneca …
Citations:
Authors: E Fountzila, V Kotoula, G Pentherdoudakis, K Manousou, E Vrettou, ...
Publication: 

438. 1 Managing Ixabepilone Adverse Events With Dose Reduction Vicente Valero 7 Breast Cancer Stem Cells: A Novel Therapeutic Target Sudeshna Gangopadhyay, Argha Nandy, Pooja Hor …
Citations:
Authors: F Zagouri, TN Sergentanis, D Chrysikos, C Dimitrakakis, A Tsigginou, ...
Publication: 

439. Name of journal: World Journal of Clinical Cases ESPS Manuscript NO: 11010 Columns: Retrospective Study Adjuvant chemotherapy and acute toxicity in hypofractionated …
Citations:
Authors: V Kouloulias, E Kypraiou, J Georgakopoulos, Z Thrapsanioti, I Beli, ...
Publication: 

440. BREAST CANCER DURING PREGNANCY. TWENTY FIVE YEARS EXPERIENCE
Citations:
Authors: M Theodora, C Ambela, A Keramopoulos, K Dimitrakakis, ...
Publication: Journal of Perinatal Medicine 35

441. The recent progress of neoadjuvant chemotherapy in triple negative breast cancer: A short review
Citations:
Authors: M Liontos, S Karageorgopoulou, V Michalaki, J Contis, E Bournakis, ...
Publication: 
